Inderjit Singh Bansal

Background

About Inderjit Singh Bansal

At Mint Pharmaceuticals, I focus on the strategic development of a diversified product portfolio encompassing Orals, Injectables, Ophthalmics, Respiratory, and Topical dosage forms. My role centers on identifying, evaluating, and advancing opportunities through global licensing, partnerships, and patent-barrier analysis to drive sustainable growth and early market access. I work collaboratively with internal leadership, external IP counsels, and global manufacturing partners to assess early launch and complex generic opportunities, ensuring regulatory and commercial alignment that strengthens Mint’s presence in Canada. With over 19 years of experience in portfolio management, patent navigation, and competitive intelligence, I remain dedicated to bridging global capabilities with patient-centric outcomes. My background in IPR-NDDS and formulation science, coupled with a strong business orientation, enables me to connect technical feasibility with commercial potential. I’m motivated by the pursuit of innovation through partnership, continuously reinforcing Mint Pharmaceuticals’ position as a trusted bridge between global manufacturing excellence and the Canadian healthcare market.